Refractory vasculitic ulcer of the toe in adolescent suffering from Systemic Lupus Erythematosus treated successfully with hyperbaric oxygen therapy

Italian Journal of Pediatrics

Volumn 36, Issue 1, 2010, Pages

  Olivieri, Alma N ^a   Mellos, Antonio ^a   Duilio, Carlo ^b   Di Meglio, Milena ^a   Mauro, Angela ^a   Perrone, Laura ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CEMSI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CARBONATE; CARDIOLIPIN ANTIBODY; COLECALCIFEROL; HYDROXYCHLOROQUINE; LUPUS ANTICOAGULANT; PREDNISONE; RANITIDINE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; FAMILY HISTORY; FEMALE; HUMAN; HYPERBARIC OXYGEN; IMMUNOTHERAPY; LABORATORY TEST; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; VASCULITIS; WOUND CARE; FOOT ULCER; TOE;

ADOLESCENT; FEMALE; FOOT ULCER; HUMANS; HYPERBARIC OXYGENATION; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TOES; VASCULITIS;

EID: 79952198087     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-36-72     Document Type: Article

References (12)

1. Clinical approach to cutaneous vasculitis. Chen KR, Carlson JA, Am J Clin Dermatol 2008 9 2 71 92 10.2165/00128071-200809020-00001 18284262 (Pubitemid 351280952)
2. Hyperbaric oxygen therapy for nonhealing vasculitic ulcers. Efrati S, Bergan J, Fishlev G, Tishler M, Golik A, Gall N, Clinical Exp Dermatol 2007 32 1 12 7 (Pubitemid 46006358)
3. Successful treatment of gangrene in systemic necrotizing vasculitis with iloprost. Zulian F, Costantini C, Montesco MC, Schiavon F, Zacchello F, Br J Rheumatol 1998 37 2 228 30 10.1093/rheumatology/37.2.228 9569082
4. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases. Zulian F, Corona F, Gerloni V, Falcini F, Buoncompagni A, Scarazatti M, Martini G, Zacchello F, Rheumatology 2004 43 2 229 33 10.1093/rheumatology/keg480 12923288 (Pubitemid 38219681)
5. Iloprost treatment for refractory Raynaud 's phenomenon in two infants. Shouval DS, Mukamel M, Zulian F, Amir J, Harel L, Clin Exp Rheumatol 2008 26 Suppl 49 105 S107 18799065
6. Improvement of cutaneous polyarteritis nodosa lesions with hyperbaric oxygen. Mazokopakis EE, Milkas AN, Tsartsalis AN, Karefilakis CM, Besmertis LP, Int J Dermatol 2009 48 2 1023 1025 10.1111/j.1365-4632.2009.04089.x 19702999
7. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy. Lui NL, Thumboo J, Fong KY, Int J Rheum Dis 2009 12 4 366 9 10.1111/j.1756-185X.2009.01438.x 20374378
8. Validation of a diabetic wound classification system. The contribution of depth, infection and ischemia to risk of amputation. Armstrong DG, Lavery LA, Harkless LB, Diabetes Care 1998 21 5 855 9 10.2337/diacare.21.5.855 9589255 (Pubitemid 28487086)
9. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Gill AL, Bell CN, Q J Med 2004 97 7 385 395 (Pubitemid 38967412)
10. Hyperbaric oxygenation and wound healing. Broussard CL, J Vasc Nurs 2004 22 2 42 8 10.1016/j.jvn.2004.03.001 15179416
11. The role of oxygen in wound healing: a review of the literature. Rodriguez PG, Felix FN, Woodley DT, Shim EK, Dermatol Surg 2008 34 9 1159 69 10.1111/j.1524-4725.2008.34254.x 18513296
12. Hyperbaric-oxygen therapy. Tibbles PM, Edelsberg JS, N Engl J Med 1996 334 25 1642 1648 10.1056/NEJM199606203342506 8628361 (Pubitemid 26192525)